Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2021 Update
Gaucher Disease Type III Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Phosphodiesterase 3 (PDE3 or EC 3.1.4.17) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Apolipoprotein C III (APOC3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
D3 Dopamine Receptor (Dopamine D3 Receptor or DRD3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players